Medium urgency

Maryland Expands Prescriber–Pharmacist Agreements and Opens New Opportunities for Opioid Use Disorder Treatment - bipc.com

Detected September 1, 2026 · in Pharmacy & Controlled Substances

Maryland has expanded prescriber-pharmacist agreements, creating new opportunities for opioid use disorder treatment, which may affect pharmacy operations and collaborative practice arrangements.

Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 1, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies in Maryland that engage in collaborative practice or dispense controlled substances for opioid use disorder treatment. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the provided text.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

The regulatory framework for prescriber-pharmacist agreements in Maryland has been expanded, potentially allowing pharmacists to take on new roles in opioid use disorder treatment.

Who it affects

Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies in Maryland that engage in collaborative practice or dispense controlled substances for opioid use disorder treatment.

What you must do

Review current collaborative practice agreements and assess whether they need to be updated to align with the expanded scope. Consider new opportunities for pharmacist involvement in opioid use disorder treatment.

Deadline

Not specified in the provided text.

Source: https://news.google.com/rss/articles/CBMi1wFBVV95cUxOWTlWYlFmUkt5MGpPdnExS25mNmZxeVlCUU41U2FSenM0UzRobXU0WVVUbnd0cDJvLXFhWWhObFZpNm1RZWU3VU12RDJiMWlhT1ZzcFFYY28yWWFwbjJFb3NIZVpicTNEWVVfa3VZWExGUFdUbng4N2pUenYyQ19JQ3VpMjhodzhqQnpiS3k3aFp2cFRwXzBwNmJRQWFRVXVZajM5aVdtTFhJOFBZYWVSNVRtMDRnY3FUWTZNaUNZaWNsMXpmbnNQMmJDYm9lVjctX0EyVEVTRQ?oc=5

Never miss a change like this again

Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmacy & Controlled Substances